The journal Nature Medicine recently published an article about an enzyme therapy that may prevent skeletal abnormalities associated with NF1. This research, conducted by Vanderbilt University’s Dr. Florent Elefteriou, PhD, and Dr. Jean de la Croix Ndong, PhD, was supported by a Young Investigator Award from the Children’s Tumor Foundation.
Please click here for more information.